Litcius/Paper detail

MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial

Sangeet Ghai, Antonio Finelli, Kateri Corr, Katherine Lajkosz, Stuart A. McCluskey, Rosanna Chan, Mark R. Gertner, Theodorus van der Kwast, Peter Incze, Alexandre R. Zlotta, Walter Kucharczyk, Nathan Perlis

2024Radiology16 citationsDOI

Abstract

MRI-guided focal therapy (FT) allows for accurate targeting of localized clinically significant prostate cancer (csPCa) while preserving healthy prostate tissue, but the long-term outcomes of this approach require more study.

Topics & Concepts

MedicineProstate cancerProstateQuality of life (healthcare)Adverse effectBiopsyHigh-intensity focused ultrasoundProspective cohort studyMagnetic resonance imagingContouringCancerRadiologyUrologyUltrasoundSurgeryInternal medicineEngineeringEngineering drawingNursingProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchUrologic and reproductive health conditions
MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial | Litcius